Skip to content

Developing a Digital Handover Application for Paramedics to Provide a Personalized Approach to Pre-hospital Stratification for Out of Hospital Cardiac Arrest

Developing a Digital Handover Application for Paramedics to Provide a Personalized Approach to Pre-hospital Stratification for Out of Hospital Cardiac Arrest

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05185063
Acronym
RAPID-MIRACLE
Enrollment
500
Registered
2022-01-11
Start date
2022-03-01
Completion date
2024-03-01
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Out of Hospital Cardiac Arrest

Brief summary

A prospective study validating the role of the MIRACLE2 score in patients with resuscitated out of hospital cardiac arrest in a pre-hospital setting.

Detailed description

Design: Prospective observational cohort study enrolling OOHCA patients across London in a pre-hospital setting Study Protocol: Patients with OOHCA and ROSC will be recruited from the community into the study by London Ambulance Service NHS Trust (LAS). LAS has -40 Advanced Paramedic Practitioners in Critical Care (APP-CC) who have a range of specialist skills including airway management and focused ultrasound and attend to over 1500 OOHCAs/year. Point of Care pH test: The recruited participants will have point of care pH testing performed using the CG4+ iStat system (Abbott Vascular, Illinois, U.S.A.). The test requires 2ml of venous blood and can provide blood results within minutes. The device and blood taking system have received CE marking and are already in routine use across the NHS. Once the blood results are received, the blood sample and testing system are discarded in a routine manner. Standard Care: Participants will then be conveyed to either the local emergency department or to a HAC based on current routine protocols. Patients will be treated in a routine manner after reaching secondary care in accordance with local and national guidance with no change in care based on this study. Power calculation: In 2019, APP-CCs from LAS attended to -700 OOHCA patients with ROSC. Assuming 60% recruitment, we could comfortably envisage -500 patients to be recruited in a 15 month period. From previous data, we can expect approximately 60% of the patients (n=300) to have a CPC score of 3-5 on hospital discharge. This would be of a similar size to the dataset used to derive the original score, which gave good levels of accuracy in model performance measures.

Interventions

DIAGNOSTIC_TESTPoint of Care blood test

The pH will be incorporated into the MIRACLE2 score in a pre-hospital setting. The patients will continue to be treated with standard of care.

Sponsors

London Ambulance Service NHS Trust
CollaboratorOTHER
King's College Hospital NHS Trust
CollaboratorOTHER
King's College London
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with out of hospital cardiac arrest with sustained ROSC (defined as \>20 minutes or sufficient stability to consider conveyance)

Exclusion criteria

* Any clear non-cardiac cause of arrest (trauma, drowning Overdose, asphyxia, asthma, anaphylaxis). * Suspected or confirmed intra-cerebral bleeding * Known CPC score 3 or 4 pre-cardiac arrest * Known disease limiting survival to 6 months * Suspected or known pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Cerebral Performance Category at 30 days40 datsCerebral Performance Category

Secondary

MeasureTime frameDescription
All cause mortality at 30 days30 daysDeath from any cause
Cause of Death at 30 days30 daysCause of death defined as neurological,multi-organ dysfunction syndrome, cardiac or unrelated
Cerebral Performance Category at 6 months6 monthsCerebral Performance Category
All cause mortality at 6 months6 monthsDeath from any cause
Cause of Death at 6 months6 monthsCause of death defined as neurological,multi-organ dysfunction syndrome, cardiac or unrelated

Contacts

Primary ContactNilesh Pareek, MA,MRCP,PhD
nileshpareek@nhs.net02032999000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026